COMMUNIQUÉS West-GlobeNewswire

Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer

04/12/2017 - 14:30

VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies

04/12/2017 - 14:30

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

FDA Selects HemoStyp® for CtQ Pilot Program

04/12/2017 - 14:30

HENDERSON, Nev., Dec. 04, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry

04/12/2017 - 14:30

Miami, FL , Dec. 04, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire “Stock Day” host Everett Jolly warmly welcomes back a long awaited guest Shital Mars, CEO of Progressive Care Inc. (OTCPink: RXMD) (“Progressive Care” or the [...]

Canadian Blood Services board meeting open to the public

04/12/2017 - 14:00

OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- On Dec. 7, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]

La réunion du conseil d’administration de la Société canadienne du sang ouverte au public

04/12/2017 - 14:00

OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion de son conseil d’administration. La réunion aura lieu le 7 décembre à Ottawa [...]

CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel

04/12/2017 - 14:00

NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel

04/12/2017 - 14:00

NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab Inc.

04/12/2017 - 14:00

VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ” or the “ Company ”) (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce that it has entered into a share purchase agreement [...]

CorVel Successfully Implements CareMC Edge

04/12/2017 - 14:00

IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL ) announced today the successful implementation of their CareMC Edge data integration tool for the insurance carrier marketplace. [...]

The American Health Council Physician Board Welcomes Indrani Hightower, MD

04/12/2017 - 14:00

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Indrani Sen Hightower, MD as an affiliate of its Physician Board. She has spent the last two years as a Neurologist at [...]

XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative Dermatology

04/12/2017 - 14:00

AUSTIN, Texas, Dec. 04, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today the publication of data from its randomized phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment [...]

Emblem Corp. Provides Business Update for 2018

04/12/2017 - 14:00

TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically integrated cannabis company focused on research, development, production and distribution of cannabis [...]

Daré Bioscience, Inc. to Present at the LD Micro 10th Annual Main Event Conference

04/12/2017 - 14:00

SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a healthcare company committed to the development and commercialization of innovative products in women’s reproductive health, today [...]

Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

04/12/2017 - 14:00

ZX008 Patients More Likely to Achieve Clinically Meaningful Reduction in Seizure Frequency Compared to Those on Placebo Parents/Caregivers and Investigators Rated Patients Treated with ZX008 as Very Much Improved or [...]

Oncolix, Inc. Expands Board of Directors with New Appointment

04/12/2017 - 13:30

HOUSTON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc. (OTC PINK:ONCX) (the “Company”), a biotechnology company focused on gynecological cancers, announced the appointment of John W. Holaday, Ph.D., to the Company’s [...]

Cutera Announces Appointment of Sandra Gardiner as CFO

04/12/2017 - 13:30

BRISBANE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced the [...]

Ultragenyx and Kyowa Kirin Announce Positive 48-Week Data from Adult Phase 3 Study of Burosumab (KRN23) in X-Linked Hypophosphatemia

04/12/2017 - 13:30

NOVATO, Calif. and TOKYO and LONDON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare [...]

ProMIS Neurosciences Announces Trading on OTCQB Venture Market

04/12/2017 - 13:30

TORONTO and CAMBRIDGE, Mass., Dec. 04, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced that [...]